Priority Date: 30.11.11 (WO 2011EP06003)

USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF DRY EYE SYNDROME

  • Application ID: EP12798160
  • Status: APPLICATION WITHDRAWN

Attorney

no operation time available
Headquarter in Munich
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 30.11.2011 - Priority Date (WO 2011EP06003)
  • 06.06.2013 - Publication A1 (WO2013079213)
  • 08.10.2014 - Publication A1 (EP2785363)